Literature DB >> 24507522

Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation.

Jeffrey M Gelfand1.   

Abstract

The diagnosis of multiple sclerosis (MS) is based on demonstrating evidence of inflammatory-demyelinating injury within the central nervous system that is disseminated in both time and space. Diagnosis is made through a combination of the clinical history, neurologic examination, magnetic resonance imaging and the exclusion of other diagnostic possibilities. Other so-called "paraclinical" tests, including the examination of the cerebrospinal fluid, the recording of evoked potentials, urodynamic studies of bladder function, and ocular coherence tomography, may be helpful in establishing the diagnosis for individual patients, but are often unnecessary. Differential diagnosis in MS must be guided by clinical presentation and neurologic localization. While the list of conditions that can mimic MS clinically or radiologically is long, in clinical practice there are few conditions that truly mimic MS on both fronts. A positive test for a putative MS "mimic" does not unto itself exclude the diagnosis of MS. Typical symptoms of MS include discrete episodes ("attacks" or "relapses") of numbness, tingling, weakness, vision loss, gait impairment, incoordination, imbalance, and bladder dysfunction. In between attacks, patients tend to be stable, but may experience fatigue and heat sensitivity. Some MS patients go on to experience, or only experience, an insidious worsening of neurologic function and accumulation of disability ("progression") that is not associated with discrete relapse activity. Progression accounts for most of the long-term disability in MS. Diagnostic criteria for MS have evolved over the past several decades, with each revision impacting the apparent prevalence and prognosis of the disorder - the result has been to encourage earlier diagnosis without compromising accuracy.
© 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnostic Criteria; MRI; Prognosis; Progression; Relapse; magnetic resonance imaging; myelitis; optic neuritis

Mesh:

Year:  2014        PMID: 24507522     DOI: 10.1016/B978-0-444-52001-2.00011-X

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  28 in total

1.  Therapeutic management of severe relapses in multiple sclerosis.

Authors:  Carolyn Bevan; Jeffrey M Gelfand
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

2.  The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease.

Authors:  Mario Tranfa; Mario Tortora; Giuseppe Pontillo; Valentina Iuzzolino; Eleonora Riccio; Simona Caccavallo; Teodolinda Di Risi; Serena Monti; Roberta Lanzillo; Vincenzo Brescia Morra; Giuseppe Palma; Maria Petracca; Antonio Pisani; Arturo Brunetti; Sirio Cocozza
Journal:  Eur Radiol       Date:  2022-01-14       Impact factor: 5.315

Review 3.  Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.

Authors:  Julia Doroszkiewicz; Magdalena Groblewska; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

Review 4.  Brain Structural and Functional Alterations in Multiple Sclerosis-Related Fatigue: A Systematic Review.

Authors:  Chiara Barbi; Francesca Benedetta Pizzini; Stefano Tamburin; Alice Martini; Anna Pedrinolla; Fabio Giuseppe Laginestra; Gaia Giuriato; Camilla Martignon; Federico Schena; Massimo Venturelli
Journal:  Neurol Int       Date:  2022-06-08

5.  Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings in Multiple Sclerosis Patients.

Authors:  Ayşe Balıkçı; Neslihan Parmak Yener; Meral Seferoğlu
Journal:  Neuroophthalmology       Date:  2021-08-20

Review 6.  Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.

Authors:  Hussein Abou-Abbass; Hadi Abou-El-Hassan; Hisham Bahmad; Kazem Zibara; Abir Zebian; Rabab Youssef; Joy Ismail; Rui Zhu; Shiyue Zhou; Xue Dong; Mayse Nasser; Marwan Bahmad; Hala Darwish; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-04-04       Impact factor: 3.535

7.  Education, and the balance between dynamic and stationary functional connectivity jointly support executive functions in relapsing-remitting multiple sclerosis.

Authors:  Sue-Jin Lin; Irene Vavasour; Brenda Kosaka; David K B Li; Anthony Traboulsee; Alex MacKay; Martin J McKeown
Journal:  Hum Brain Mapp       Date:  2018-09-21       Impact factor: 5.038

Review 8.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

Review 9.  Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.

Authors:  Nazem Ghasemi; Shahnaz Razavi; Elham Nikzad
Journal:  Cell J       Date:  2016-12-21       Impact factor: 2.479

Review 10.  C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective.

Authors:  Giselle Pentón-Rol; Javier Marín-Prida; Viviana Falcón-Cama
Journal:  Behav Sci (Basel)       Date:  2018-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.